Clinical Trials Directory

Trials / Unknown

UnknownNCT05321030

Correlation Between Smartphone Addiction and Back Dysfunction and Core Muscle Morphology and Performance in Asymptomatic Young Adults

Status
Unknown
Phase
Study type
Observational
Enrollment
136 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers

Summary

The purpose of this study is to investigate the association between smartphone addiction and back pain, function, and lumbar stabilizer cross-sectional area and thickness compared with non-addicted teenagers.

Detailed description

Smartphone prolonged use has been suggested as a risk factor for psychological, visual, and musculoskeletal dysfunctions. The musculoskeletal dysfunction may be related to direct contact use with smartphones as in thumb, elbow, and neck pain. Moreover, indirect long use of smartphones may affect thoracic, lumbar, and lower limbs. COVID-19 pandemic occurred in a time of outstanding scientific progress and global digitalization. Therefore, smartphone usage became a must for human connection, learning, and entertainment, providing psychological and social support. In the meantime, it was observed a significant increase in overuse and addiction, especially in young and teenage females. The addiction is associated with more musculoskeletal abnormalities when compared to non-addict users. Several studies found an association between smartphone usage and back pain, concomitant with a reduction in thoracic extensors activity. This back pain may affect their quality of life and work-related productivity. However, the relationship between back dysfunction and smartphone addiction is still unclear. A few attempts were done to elucidate this relationship. Yet if proven correct, then preventive measures such as recommendations and precautions regarding smartphone use could be distributed to users by the manufacturers. Furthermore, engineering solutions are needed to optimally design smartphones to alter their weight and sizes to minimize potential adverse effects.

Conditions

Timeline

Start date
2022-04-01
Primary completion
2022-06-01
Completion
2022-06-15
First posted
2022-04-11
Last updated
2022-04-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05321030. Inclusion in this directory is not an endorsement.